<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Avian influenza: Clinical manifestations and diagnosis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Avian influenza: Clinical manifestations and diagnosis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Avian influenza: Clinical manifestations and diagnosis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Iain Stephenson, MD, FRCP</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Martin S Hirsch, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Elinor L Baron, MD, DTMH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jun 16, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The clinical manifestations of avian influenza are determined in part by the pathogenicity of the virus and subtype. The classification of avian influenza viruses as high pathogenicity avian influenza (HPAI) or low pathogenicity avian influenza (LPAI) viruses is based on specific molecular criteria and pathogenicity in birds [<a href="#rid1">1</a>]. Both HPAI and LPAI viruses are capable of causing caused a wide range of human disease. Avian influenza virus subtypes H5N1 and H7N9 have been associated with the greatest public health impact, numerically as well as in terms of disease severity.</p><p>The clinical manifestations and diagnosis of avian influenza will be reviewed here. The epidemiology, transmission, treatment, and prevention of avian influenza are discussed separately. (See  <a class="medical medical_review" href="/d/html/7002.html" rel="external">"Avian influenza: Epidemiology and transmission"</a> and  <a class="medical medical_review" href="/d/html/138869.html" rel="external">"Avian influenza: Treatment and prevention"</a> and  <a class="medical medical_review" href="/d/html/7000.html" rel="external">"Avian influenza vaccines"</a>.)</p><p class="headingAnchor" id="H1292638881"><span class="h1">EPIDEMIOLOGY AND RISK FACTORS</span><span class="headingEndMark"> — </span>Risk factors for human infection with avian influenza viruses include [<a href="#rid2">2</a>] (see <a class="local">'Whom to test'</a> below): </p><p class="bulletIndent1"><span class="glyph">●</span>Close exposure or direct contact with infected live poultry (well appearing or sick) or poultry products</p><p class="bulletIndent1"><span class="glyph">●</span>Close, unprotected exposure to a person with avian influenza virus infection and respiratory illness</p><p></p><p>Issues related to transmission are discussed further separately. (See  <a class="medical medical_review" href="/d/html/7002.html" rel="external">"Avian influenza: Epidemiology and transmission", section on 'Transmission'</a>.)</p><p class="headingAnchor" id="H3305487220"><span class="h1">CLINICAL MANIFESTATIONS</span></p><p class="headingAnchor" id="H2240668320"><span class="h2">Incubation period</span><span class="headingEndMark"> — </span>The incubation period for human infection with avian influenza H5N1 and H7N9 viruses is generally three to five days but may be as long as 7 to 10 days [<a href="#rid3">3-7</a>].</p><p class="headingAnchor" id="H4228392277"><span class="h2">General principles</span><span class="headingEndMark"> — </span>The spectrum of manifestations associated with avian influenza infection is broad and depends on the specific virus as well as host characteristics. Infected individuals may be asymptomatic or present with a range of manifestations including mild focal illness (such as conjunctivitis), uncomplicated upper respiratory illness, or fulminant pneumonitis with multiorgan failure [<a href="#rid1">1</a>].</p><p>Signs and symptoms may include fever, cough, dyspnea, chest pain, and myalgia; malaise, headache, diarrhea, and sore throat can occur but are less common. Gastrointestinal manifestations such as abdominal pain, vomiting, and diarrhea are variable.</p><p>Complications may include pneumonia, respiratory failure, acute kidney injury, rhabdomyolysis, disseminated intravascular coagulation, meningoencephalitis, and coinfection with bacterial or fungal pathogens. </p><p class="headingAnchor" id="H3"><span class="h2">Avian influenza H5N1</span><span class="headingEndMark"> — </span>H5N1 infection can result in mildly symptomatic illness to life-threatening disease. The clinical presentation may depend on several factors including the nature of the exposure and the virus clade [<a href="#rid8">8-11</a>]. Important features of prior H5N1 outbreaks include the predominance of children and young adults and the high mortality rate [<a href="#rid12">12,13</a>]. </p><p class="headingAnchor" id="H5"><span class="h3">Signs and symptoms</span><span class="headingEndMark"> — </span>Most common clinical presentations include fever and cough; other manifestations may include sore throat, nasal congestion, headache, myalgia, or diarrhea; uncommonly, conjunctivitis or bleeding gums may be observed [<a href="#rid11">11,14,15</a>]. Patients with gastrointestinal or central nervous system involvement in the absence of respiratory symptoms have also been described [<a href="#rid16">16</a>]. There have been several case reports of children with fatal encephalitis confirmed by polymerase chain reaction (PCR) detection of H5N1 virus in cerebrospinal fluid, usually in association with concurrent respiratory disease [<a href="#rid16">16-18</a>].</p><p>The following observations illustrate the range of findings:</p><p class="bulletIndent1"><span class="glyph">●</span>In the 1997 H5N1 outbreak in Hong Kong including 18 patients, 8 patients were &lt;12 years of age and all but one had relatively mild disease [<a href="#rid11">11,19</a>]. The most severe infections occurred in patients &gt;12 years of age.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a study including 67 hospitalized patients in Vietnam with clade 1 H5N1 influenza infection between 2004 and 2006, the median age was 25 [<a href="#rid20">20</a>]. Common manifestations were fever (75 percent), cough (89 percent), dyspnea (81 percent), bilateral pulmonary infiltrates (72 percent), lymphopenia (73 percent), and elevated aminotransferases concentrations (aspartate aminotransferase [AST], 69 percent; alanine aminotransferase [ALT], 61 percent). Diarrhea and mucosal bleeding at presentation were more common among patients who died. The risk of death was highest among individuals ≤16 years of age.</p><p></p><p>Risk factors associated with severe disease include delayed hospital admission and the presence of bilateral pneumonia [<a href="#rid9">9-11,21</a>]. In one study including 67 patients, neutropenia and increased ALT concentration at presentation were predictive of a fatal outcome [<a href="#rid20">20</a>].</p><p>Complications include multiorgan failure with renal dysfunction and cardiac compromise, pulmonary hemorrhage, pneumothorax, and pancytopenia [<a href="#rid14">14,15</a>]. Most deaths have been related to respiratory failure. </p><p class="headingAnchor" id="H1062523956"><span class="h3">Laboratory and radiographic findings</span><span class="headingEndMark"> — </span>Patients with severe disease often have leukopenia, neutropenia, lymphopenia, and thrombocytopenia on hospital admission [<a href="#rid9">9-11,19-23</a>]. Other laboratory abnormalities may include elevated levels of aminotransferases (AST&gt;ALT) [<a href="#rid9">9,10,20</a>], lactate dehydrogenase, creatine kinase [<a href="#rid9">9</a>], and hypoalbuminemia [<a href="#rid10">10</a>].</p><p>Radiographic findings of H5N1 avian influenza include diffuse, multifocal, or patchy infiltrates, interstitial infiltrates, and segmental or lobular consolidation [<a href="#rid15">15</a>]. Pleural effusions are usually not seen [<a href="#rid9">9,10</a>]. Progression to respiratory failure is associated with diffuse bilateral ground-glass infiltrates [<a href="#rid21">21</a>].</p><p class="headingAnchor" id="H3204268852"><span class="h2">Avian influenza H7N9</span></p><p class="headingAnchor" id="H3192702975"><span class="h3">Signs and symptoms</span><span class="headingEndMark"> — </span>Signs and symptoms may include fever, cough, dyspnea, headache, myalgia, and malaise [<a href="#rid6">6,24-26</a>]. Respiratory tract infection may progress to severe pneumonia [<a href="#rid27">27,28</a>]. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Severe disease</strong> − In case reports and case series, clinical features of severe include fulminant pneumonia, respiratory failure, acute respiratory distress syndrome (ARDS), septic shock, multiorgan failure, rhabdomyolysis, disseminated intravascular coagulation, and encephalopathy [<a href="#rid5">5,25,29,30</a>]. </p><p></p><p class="bulletIndent1">Various series have described cases of severe avian influenza A H7N9 infection [<a href="#rid5">5,6,24,31-34</a>]. </p><p></p><p class="bulletIndent1">In one study including 111 patients hospitalized with avian influenza A H7N9 infection in China, 77 percent were admitted to an intensive care unit and 27 percent died [<a href="#rid24">24</a>]. The most common presenting clinical manifestations were fever (100 percent) and cough (90 percent). The majority of patients had sputum production (56 percent) and shortness of breath (56 percent). Some (14 percent) had diarrhea or vomiting. At the time of admission, 97 percent had findings consistent with pneumonia. No patients had conjunctivitis, in contrast with past outbreaks of avian influenza H7 infection in the Netherlands and elsewhere. (See  <a class="medical medical_review" href="/d/html/7002.html" rel="external">"Avian influenza: Epidemiology and transmission"</a>.)</p><p></p><p class="bulletIndent1">The most common complications were moderate to severe ARDS (in 71 percent), shock (26 percent), acute kidney injury (16 percent), and rhabdomyolysis (10 percent) [<a href="#rid24">24</a>]. The median time from onset of illness to ARDS was 7 days (range 1 to 19 days) and from illness onset to shock was 8 days (range 3 to 55 days). Of the 79 patients with ARDS, 65 required mechanical ventilation, and, of these, 20 went on to receive extracorporeal membrane oxygenation. On multivariate analysis, the presence of a coexisting medical condition was the only independent risk factor for the development of moderate to severe ARDS (odds ratio 3.4, 95% CI 1.2-9.7). </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Mild or moderate disease</strong> − Most patients described with avian influenza A H7N9 infection have been severely ill; however, mild and moderate disease also occurs. </p><p></p><p class="bulletIndent1">Using China's national sentinel surveillance system in outpatient clinics and emergency departments of 554 sentinel hospitals across 31 provinces, a subset of patients with influenza-like illness underwent testing for avian influenza A H7N9 via reverse transcription-PCR of nasopharyngeal swabs [<a href="#rid35">35</a>]. Among 130 individuals with laboratory-confirmed infection, 4 percent were detected using the sentinel surveillance system. The mean age of these patients was 13 years (range 2 to 26) and none had any underlying medical conditions. All presented with fever and most had upper respiratory tract symptoms; one had pneumonia. Only two of the five patients required hospitalization and all recovered uneventfully.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Asymptomatic infection</strong> – Most reports have shown that individuals in Asia generally lack pre-existing immunity to avian influenza A H7N9 [<a href="#rid36">36-40</a>]; however, some data suggest immunity in a subset of poultry workers [<a href="#rid41">41,42</a>]. In a surveillance study among 1129 individuals in H7N9 outbreak areas of China, no seropositivity for avian-origin H7N9 virus was observed; however, among 396 poultry workers, 6 percent had hemagglutination inhibition antibody titers ≥80, suggesting past or subclinical infection [<a href="#rid41">41</a>].</p><p></p><p class="headingAnchor" id="H588426540"><span class="h3">Laboratory and radiographic findings</span><span class="headingEndMark"> — </span>In a study of 111 hospitalized patients with avian influenza A H7N9 infection, 88 percent had lymphopenia and 73 percent had thrombocytopenia [<a href="#rid24">24</a>]. The white blood cell count was normal or slightly decreased in most patients. Elevated levels of AST, ALT, lactate dehydrogenase, creatine kinase, and C-reactive protein have been reported [<a href="#rid24">24,34</a>].</p><p>On chest radiograph and computed tomography (CT) scanning, patients with pneumonia have had multilobar patchy consolidations and diffuse ground-glass opacities  (<a class="graphic graphic_diagnosticimage graphicRef89432" href="/d/graphic/89432.html" rel="external">image 1</a> and <a class="graphic graphic_diagnosticimage graphicRef89433" href="/d/graphic/89433.html" rel="external">image 2</a>) [<a href="#rid24">24,25,43-45</a>]. Other CT findings may include air bronchograms, interlobular septal thickening, centrilobular nodules, reticular opacities, cystic changes, bronchial dilatation, and subpleural linear opacities [<a href="#rid43">43</a>].</p><p class="headingAnchor" id="H3647838042"><span class="h2">Other avian influenza strains</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Avian influenza H5N6</strong> − Avian influenza H5N6 viruses have been isolated from several individuals in China since 2014; patients have presented with a spectrum of clinical manifestations ranging from mild respiratory symptoms to severe pneumonia and death [<a href="#rid46">46-50</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Avian influenza H6N1</strong> − Avian influenza H6N1 was isolated from a previously healthy 20-year-old woman with who presented with lower respiratory symptoms and pneumonia [<a href="#rid51">51</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Avian influenza H7</strong> − Avian influenza H7N7 and H7N3 appear to have a predilection for conjunctival epithelium and may present with isolated conjunctivitis following direct contact with poultry or contaminated material (such as feathers, feces, or eggs) [<a href="#rid52">52-54</a>]. In one survey of poultry workers and their families potentially exposed during the 2003 Netherlands H7N7 outbreak, 349 individuals had conjunctivitis (among whom 83 cases of avian influenza H7N7 were confirmed), while 90 individuals had symptoms of influenza-like illness (among whom 5 cases of avian influenza H7N7 were confirmed) [<a href="#rid52">52</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Avian influenza H9N2</strong> − Children infected with avian H9N2 influenza viruses have presented with mild, self-limited upper respiratory illnesses [<a href="#rid50">50,55-57</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Avian influenza H10</strong> – Avian influenza H10N3, H10N7, and H10N8 have been isolated from individuals presenting with respiratory symptoms ranging from self-limiting mild upper respiratory tract illness to fatal, severe rapidly progressive pneumonia [<a href="#rid58">58-61</a>].</p><p></p><p class="headingAnchor" id="H946043820"><span class="h1">DIAGNOSIS</span></p><p class="headingAnchor" id="H3496437090"><span class="h2">Case definitions</span><span class="headingEndMark"> — </span>The United States Centers for Disease Control and Prevention (CDC) has outlined the following case definitions for avian influenza [<a href="#rid62">62</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Confirmed Case</strong> – A person with laboratory confirmed avian influenza A virus infection.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Suspected Case </strong>(also called <strong>Case Under Investigation</strong>) – A person meeting clinical and epidemiologic criteria for avian influenza A virus infection (see <a class="local">'Whom to test'</a> below) and for whom confirmatory laboratory test results are unknown or pending.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Probable Case</strong> – A person meeting clinical and epidemiologic criteria for avian influenza A virus infection (see <a class="local">'Whom to test'</a> below) and for whom laboratory test results do not provide sufficient level of detail to confirm avian influenza virus infection.</p><p></p><p class="headingAnchor" id="H714856568"><span class="h2">Whom to test</span><span class="headingEndMark"> — </span>The diagnosis of avian influenza should be suspected in patients who present with clinical criteria <strong>and</strong> epidemiologic criteria as outlined below [<a href="#rid62">62</a>]. Patients being evaluated for avian influenza should begin empiric antiviral treatment and be placed on appropriate infection control precautions. (See  <a class="medical medical_review" href="/d/html/138869.html" rel="external">"Avian influenza: Treatment and prevention"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical criteria</strong> − Clinical criteria include any of the following [<a href="#rid62">62</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Mild flu-like illness (cough, sore throat, fever or feeling feverish, rhinorrhea, fatigue, myalgia, arthralgia, headache) or conjunctivitis (red eye, discharge from eye)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Moderate to severe illness including shortness of breath or difficulty breathing, altered mental status, seizures </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Complications including pneumonia, respiratory failure, acute respiratory distress syndrome, multiorgan failure, or meningoencephalitis</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiologic criteria</strong> – Epidemiologic criteria include any of the following [<a href="#rid62">62</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Exposure to infected birds</strong> – Recent (within ten days of illness onset), close (within two meters), and unprotected (without use of respiratory and eye protection) exposure to sick or dead birds with confirmed avian influenza virus infection by A(H5), A(H7), or A(H9) viruses; birds include including poultry, wild aquatic birds, or captive birds of prey that have had contact with aquatic birds. Exposure includes any of the following [<a href="#rid63">63</a>]:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Handling, slaughtering, defeathering, butchering, culling, or preparation of birds for consumption</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Direct contact with surfaces contaminated by infected bird secretions, excretions, or remains</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Visiting a live poultry market with confirmed bird infection or associated with a case of human infection [<a href="#rid64">64</a>]</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Exposure to an infected person</strong> − Recent (within 10 days of illness onset), close (within two meters), and unprotected (without use of respiratory and eye protection) exposure to a person who is a confirmed, suspected, or probable case of avian influenza virus. (See <a class="local">'Case definitions'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Exposure to secretions of an infected person<strong> – Direct, </strong>unprotected (without use of respiratory and eye protection) exposure <strong>to secretions from an infectious patient (beginning one day prior to symptom onset and continuing until symptoms resolve).</strong></p><p></p><p class="headingAnchor" id="H976110250"><span class="h2">Choice of test</span></p><p class="headingAnchor" id="H1227575604"><span class="h3">Preferred approach</span><span class="headingEndMark"> — </span>Testing for suspected avian influenza should be performed via real-time reverse-transcriptase polymerase chain reaction (RT-PCR) on a respiratory specimen [<a href="#rid2">2</a>]. The specimen should be sent to the state or regional health laboratory for RT-PCR to detect influenza virus ribonucleic acid (RNA) and to distinguish between seasonal and avian influenza. In the United States, specimens may be sent to the CDC for confirmatory testing. </p><p>Commercially available influenza tests are not capable of distinguishing between seasonal influenza A viruses (circulating among humans) and zoonotic avian influenza A viruses.</p><p>Initial diagnostic testing may be negative; RT-PCR testing should be repeated if there is a high index of suspicion [<a href="#rid9">9,64</a>]. The sensitivity and specificity of RT-PCR for diagnosis of avian influenza are 95 to 99 percent [<a href="#rid65">65,66</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Specimen type</strong> – An upper respiratory tract specimen should be obtained; acceptable specimens include [<a href="#rid2">2</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A nasopharyngeal swab, or</p><p class="bulletIndent2"><span class="glyph">•</span>A nasal aspirate or wash, or</p><p class="bulletIndent2"><span class="glyph">•</span>A nasal or nasopharyngeal swab combined with an oropharyngeal swab into one transport media vial </p><p></p><p class="bulletIndent1">If it is not possible to obtain one of the above specimen types, a single nasal swab or oropharyngeal swab may be used.</p><p></p><p class="bulletIndent1">For patients with lower respiratory tract involvement, a lower respiratory tract specimen (eg, an endotracheal aspirate or bronchoalveolar lavage fluid) should be obtained. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Specimen collection</strong> − Respiratory specimens should be obtained using a swab with a synthetic tip (eg, polyester or Dacron) and an aluminum or plastic shaft; swabs with calcium alginate or cotton tips are not recommended [<a href="#rid64">64</a>]. </p><p></p><p class="bulletIndent1">Specimens should be placed in sterile viral transport medium and shipped immediately (on ice or frozen at -70°C and then shipped on dry ice) to the biosafety level 3 laboratory. </p><p></p><p class="bulletIndent1">Specimens from patients with suspected avian influenza must be handled and processed using appropriate biosafety precautions. Clinicians must alert laboratory personnel to ensure samples are processed at the appropriate facility [<a href="#rid64">64,67</a>]. Detailed recommendations for specimen handling can be found on the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Fflu%2Favianflu%2Ftesting-reporting-lab.htm&amp;token=R4Uiw8%2FbmPVaqNHRDqpXLKjGZOFelp5v3KMPmjBAfb9EvbZddwOPnCX5iMF6S04Z4fPlmDcy4tigynGiBq8gIQ%3D%3D&amp;TOPIC_ID=7001" target="_blank">CDC website</a>.</p><p></p><p class="headingAnchor" id="H4048238709"><span class="h3">Other tests</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Serologic testing </strong>– In general, serologic testing is not helpful for diagnosis of avian influenza in acute clinical settings [<a href="#rid68">68</a>]. In such cases, serologic testing may be performed as an alternative approach if other diagnostic testing methods are not available.</p><p></p><p class="bulletIndent1">Serologic testing may be useful for epidemiologic surveillance studies and retrospective diagnosis, via hemagglutinin-inhibition or microneutralization assays that detect an increase in specific antibodies in serum collected during the acute and convalescent phases of infection. A positive result consists of a fourfold or greater increase in antibody titer between a sample obtained as soon as possible after the onset of symptoms and another obtained after at least 14 days.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Antigen tests</strong> – Rapid antigen detection assays should <strong>not</strong> be used for diagnosis of patients with suspected avian influenza [<a href="#rid64">64,69</a>]. These tests are less sensitive than RT-PCR and lack specificity in differentiating between seasonal and avian influenza [<a href="#rid9">9,10,15,21</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Viral culture</strong> – Viral culture is not recommended. </p><p></p><p class="headingAnchor" id="H454764354"><span class="h1">DIFFERENTIAL DIAGNOSIS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Respiratory viral infection</strong> − Signs and symptoms of influenza frequently overlap with those of other respiratory viral infections and may be clinically indistinguishable in the absence of diagnostic testing.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Seasonal influenza</strong> – Seasonal influenza is characterized by abrupt onset of fever, cough, and myalgia when influenza virus is circulating (in northern hemisphere, typically September to April; in southern hemisphere, typically April to September). The preferred diagnostic tool is a molecular assay (nucleic acid amplification test). (See  <a class="medical medical_review" href="/d/html/7004.html" rel="external">"Seasonal influenza in adults: Clinical manifestations and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/5973.html" rel="external">"Seasonal influenza in children: Clinical features and diagnosis"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)/coronavirus disease 2019 (COVID-19)</strong> – It can be difficult to distinguish between influenza and COVID-19 based on clinical manifestations alone [<a href="#rid70">70,71</a>]. The diagnosis of COVID-19 is established via nucleic acid amplification testing or antigen testing. A positive test result for either influenza or COVID-19 does not rule out coinfection when both viruses are circulating. (See  <a class="medical medical_review" href="/d/html/128323.html" rel="external">"COVID-19: Clinical features"</a> and  <a class="medical medical_review" href="/d/html/128404.html" rel="external">"COVID-19: Diagnosis"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Respiratory syncytial virus</strong> – Respiratory syncytial virus causes seasonal outbreaks of respiratory tract illness throughout the world, usually during the winter season. It is common among children but is also an important and often unrecognized cause of respiratory tract infection in older adults and immunocompromised patients. The diagnosis is established via a polymerase chain reaction-based assay. (See  <a class="medical medical_review" href="/d/html/5994.html" rel="external">"Respiratory syncytial virus infection: Clinical features and diagnosis in infants and children"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Common cold</strong> − The common cold can be caused by several different viruses, including rhinoviruses, parainfluenza, and coronaviruses. Compared with influenza, cold symptoms are usually milder, nasal congestion is more common, and colds rarely result in serious health problems or complications. The diagnosis is based on clinical manifestations. (See  <a class="medical medical_review" href="/d/html/6865.html" rel="external">"The common cold in adults: Diagnosis and clinical features"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Middle East respiratory syndrome coronavirus</strong> − Middle East respiratory syndrome coronavirus is a coronavirus causing severe respiratory illness that emerged in 2012 in Saudi Arabia and continues to cause infections, primarily on the Arabian peninsula. The diagnosis is established via nucleic acid amplification testing. (See  <a class="medical medical_review" href="/d/html/106589.html" rel="external">"Middle East respiratory syndrome coronavirus: Clinical manifestations and diagnosis"</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Bacterial pneumonia</strong> − Bacterial pneumonia may present as a complication of influenza or independently. Patients with bacterial pneumonia typically present with fever, dyspnea, cough, and sputum production. (See  <a class="medical medical_review" href="/d/html/7032.html" rel="external">"Clinical evaluation and diagnostic testing for community-acquired pneumonia in adults"</a>.) </p><p></p><p class="headingAnchor" id="H108634401"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.) </p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/d/html/83059.html" rel="external">"Patient education: Bird flu (avian influenza) (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H18"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Introduction</strong> − The clinical manifestations of avian influenza are determined in part by the pathogenicity of the virus. Avian influenza virus subtypes H5N1 and H7N9 have been associated with the greatest public health impact. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Incubation period</strong> – The incubation period for human infection with avian influenza H5N1 and H7N9 viruses is generally three to five days, but may be as long as 7 to 10 days. (See <a class="local">'Incubation period'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong> − The diagnosis of avian influenza should be suspected in patients who present with clinical and epidemiologic criteria as outlined below. Patients being evaluated for avian influenza should begin empiric antiviral treatment and be placed on appropriate infection control precautions. (See <a class="local">'Diagnosis'</a> above and  <a class="medical medical_review" href="/d/html/138869.html" rel="external">"Avian influenza: Treatment and prevention"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical criteria</strong> – Clinical criteria include any of the following (see <a class="local">'Whom to test'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Mild flu-like illness (cough, sore throat, fever, rhinorrhea, fatigue, myalgia, arthralgia, headache) or conjunctivitis </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Moderate to severe illness including shortness of breath or difficulty breathing, altered mental status, seizures </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Complications including pneumonia, respiratory failure, acute respiratory distress syndrome, multiorgan failure, or meningoencephalitis</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiologic criteria</strong> − Epidemiologic criteria include any of the following (see <a class="local">'Whom to test'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Exposure to infected birds</strong> − Recent (within 10 days of illness onset), close (within two meters), and unprotected (without use of respiratory and eye protection) exposure to sick or dead birds with confirmed avian influenza virus infection by A(H5), A(H7), or A(H9) viruses; birds include including poultry, wild aquatic birds, or captive birds of prey that have had contact with aquatic birds. Exposure includes any of the following:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Handling, slaughtering, defeathering, butchering, culling, or preparation of birds for consumption</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Direct contact with surfaces contaminated by infected bird secretions, excretions, or remains</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Visiting a live poultry market with confirmed bird infection or associated with a case of human infection</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Exposure to an infected person</strong> − Recent (within 10 days of illness onset), close (within two meters), and unprotected (without use of respiratory and eye protection) exposure to a person who is a confirmed, suspected, or probable case of avian influenza virus. (See <a class="local">'Case definitions'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Exposure to secretions of an infected person<strong> – Direct, </strong>unprotected (without use of respiratory and eye protection) exposure <strong>secretions from an infectious patient (beginning one day prior to symptom onset and continuing until symptoms resolve).</strong></p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Choice of test</strong> − Testing should consist of obtaining a respiratory specimen for reverse-transcriptase polymerase chain reaction to detect influenza virus RNA and to distinguish between seasonal and avian influenza. Such testing should be performed at a state or regional health laboratory; commercially available influenza tests are not capable of distinguishing between seasonal and avian influenza. Acceptable specimens are described above. (See <a class="local">'Choice of test'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Uyeki TM, Peiris M. Novel Avian Influenza A Virus Infections of Humans. Infect Dis Clin North Am 2019; 33:907.</a></li><li class="breakAll">Interim guidance on testing and specimen collection for patients with suspected infection with novel influenza A viruses with the potential to cause severe disease in humans. Centers for Disease Control and Prevention. Available at: https://www.cdc.gov/flu/avianflu/severe-potential.htm (Accessed on May 09, 2022).</li><li><a class="nounderline abstract_t">Ungchusak K, Auewarakul P, Dowell SF, et al. Probable person-to-person transmission of avian influenza A (H5N1). N Engl J Med 2005; 352:333.</a></li><li><a class="nounderline abstract_t">Wang H, Feng Z, Shu Y, et al. Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China. Lancet 2008; 371:1427.</a></li><li><a class="nounderline abstract_t">Li Q, Zhou L, Zhou M, et al. Epidemiology of human infections with avian influenza A(H7N9) virus in China. N Engl J Med 2014; 370:520.</a></li><li><a class="nounderline abstract_t">Cowling BJ, Jin L, Lau EH, et al. Comparative epidemiology of human infections with avian influenza A H7N9 and H5N1 viruses in China: a population-based study of laboratory-confirmed cases. Lancet 2013; 382:129.</a></li><li class="breakAll">Interim guidance on influenza antiviral chemoprophylaxis of persons exposed to birds with avian influenza A viruses associated with severe human disease or with the potential to cause severe human disease. Centers for Disease Control and Prevention. Available at: https://www.cdc.gov/flu/avianflu/guidance-exposed-persons.htm (Accessed on June 16, 2022).</li><li><a class="nounderline abstract_t">Webster RG, Govorkova EA. H5N1 influenza--continuing evolution and spread. N Engl J Med 2006; 355:2174.</a></li><li><a class="nounderline abstract_t">Oner AF, Bay A, Arslan S, et al. Avian influenza A (H5N1) infection in eastern Turkey in 2006. N Engl J Med 2006; 355:2179.</a></li><li><a class="nounderline abstract_t">Kandun IN, Wibisono H, Sedyaningsih ER, et al. Three Indonesian clusters of H5N1 virus infection in 2005. N Engl J Med 2006; 355:2186.</a></li><li><a class="nounderline abstract_t">Yuen KY, Chan PK, Peiris M, et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 1998; 351:467.</a></li><li><a class="nounderline abstract_t">Bartlett JG, Hayden FG. Influenza A (H5N1): will it be the next pandemic influenza? Are we ready? Ann Intern Med 2005; 143:460.</a></li><li><a class="nounderline abstract_t">Stöhr K. Avian influenza and pandemics--research needs and opportunities. N Engl J Med 2005; 352:405.</a></li><li><a class="nounderline abstract_t">Writing Committee of the Second World Health Organization Consultation on Clinical Aspects of Human Infection with Avian Influenza A (H5N1) Virus, Abdel-Ghafar AN, Chotpitayasunondh T, et al. Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med 2008; 358:261.</a></li><li><a class="nounderline abstract_t">Beigel JH, Farrar J, Han AM, et al. Avian influenza A (H5N1) infection in humans. N Engl J Med 2005; 353:1374.</a></li><li><a class="nounderline abstract_t">de Jong MD, Bach VC, Phan TQ, et al. Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N Engl J Med 2005; 352:686.</a></li><li><a class="nounderline abstract_t">Mak GCK, Kwan MY, Mok CKP, et al. Influenza A(H5N1) Virus Infection in a Child With Encephalitis Complicated by Obstructive Hydrocephalus. Clin Infect Dis 2018; 66:136.</a></li><li><a class="nounderline abstract_t">Pabbaraju K, Tellier R, Wong S, et al. Full-genome analysis of avian influenza A(H5N1) virus from a human, North America, 2013. Emerg Infect Dis 2014; 20:887.</a></li><li><a class="nounderline abstract_t">Katz JM, Lim W, Bridges CB, et al. Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts. J Infect Dis 1999; 180:1763.</a></li><li><a class="nounderline abstract_t">Liem NT, Tung CV, Hien ND, et al. Clinical features of human influenza A (H5N1) infection in Vietnam: 2004-2006. Clin Infect Dis 2009; 48:1639.</a></li><li><a class="nounderline abstract_t">Chotpitayasunondh T, Ungchusak K, Hanshaoworakul W, et al. Human disease from influenza A (H5N1), Thailand, 2004. Emerg Infect Dis 2005; 11:201.</a></li><li><a class="nounderline abstract_t">Bridges CB, Lim W, Hu-Primmer J, et al. Risk of influenza A (H5N1) infection among poultry workers, Hong Kong, 1997-1998. J Infect Dis 2002; 185:1005.</a></li><li><a class="nounderline abstract_t">Kawachi S, Luong ST, Shigematsu M, et al. Risk parameters of fulminant acute respiratory distress syndrome and avian influenza (H5N1) infection in Vietnamese children. J Infect Dis 2009; 200:510.</a></li><li><a class="nounderline abstract_t">Gao HN, Lu HZ, Cao B, et al. Clinical findings in 111 cases of influenza A (H7N9) virus infection. N Engl J Med 2013; 368:2277.</a></li><li><a class="nounderline abstract_t">Chen Y, Liang W, Yang S, et al. Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome. Lancet 2013; 381:1916.</a></li><li><a class="nounderline abstract_t">Wu S, Wu F, He J. Emerging risk of H7N9 influenza in China. Lancet 2013; 381:1539.</a></li><li><a class="nounderline abstract_t">Ke Y, Wang Y, Liu S, et al. High severity and fatality of human infections with avian influenza A(H7N9) infection in China. Clin Infect Dis 2013; 57:1506.</a></li><li><a class="nounderline abstract_t">Wang X, Jiang H, Wu P, et al. Epidemiology of avian influenza A H7N9 virus in human beings across five epidemics in mainland China, 2013-17: an epidemiological study of laboratory-confirmed case series. Lancet Infect Dis 2017; 17:822.</a></li><li><a class="nounderline abstract_t">Gao R, Cao B, Hu Y, et al. Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med 2013; 368:1888.</a></li><li><a class="nounderline abstract_t">Chang SY, Lin PH, Tsai JC, et al. The first case of H7N9 influenza in Taiwan. Lancet 2013; 381:1621.</a></li><li><a class="nounderline abstract_t">Zhang W, Wang L, Hu W, et al. Epidemiologic characteristics of cases for influenza A(H7N9) virus infections in China. Clin Infect Dis 2013; 57:619.</a></li><li><a class="nounderline abstract_t">Ke Y, Wang Y, Zhang W, et al. Deaths associated with avian influenza A(H7N9) virus in China. Ann Intern Med 2013; 159:159.</a></li><li><a class="nounderline abstract_t">Yu L, Wang Z, Chen Y, et al. Clinical, virological, and histopathological manifestations of fatal human infections by avian influenza A(H7N9) virus. Clin Infect Dis 2013; 57:1449.</a></li><li><a class="nounderline abstract_t">Wang C, Yu H, Horby PW, et al. Comparison of patients hospitalized with influenza A subtypes H7N9, H5N1, and 2009 pandemic H1N1. Clin Infect Dis 2014; 58:1095.</a></li><li><a class="nounderline abstract_t">Ip DK, Liao Q, Wu P, et al. Detection of mild to moderate influenza A/H7N9 infection by China's national sentinel surveillance system for influenza-like illness: case series. BMJ 2013; 346:f3693.</a></li><li><a class="nounderline abstract_t">Watanabe T, Kiso M, Fukuyama S, et al. Characterization of H7N9 influenza A viruses isolated from humans. Nature 2013; 501:551.</a></li><li><a class="nounderline abstract_t">Zhou J, Wang D, Gao R, et al. Biological features of novel avian influenza A (H7N9) virus. Nature 2013; 499:500.</a></li><li><a class="nounderline abstract_t">Bai T, Zhou J, Shu Y. Serologic study for influenza A (H7N9) among high-risk groups in China. N Engl J Med 2013; 368:2339.</a></li><li><a class="nounderline abstract_t">Xu W, Lu L, Shen B, et al. Serological investigation of subclinical influenza A(H7H9) infection among healthcare and non-healthcare workers in Zhejiang Province, China. Clin Infect Dis 2013; 57:919.</a></li><li><a class="nounderline abstract_t">Liu WJ, Tan S, Zhao M, et al. Cross-immunity Against Avian Influenza A(H7N9) Virus in the Healthy Population Is Affected by Antigenicity-Dependent Substitutions. J Infect Dis 2016; 214:1937.</a></li><li><a class="nounderline abstract_t">Yang S, Chen Y, Cui D, et al. Avian-origin influenza A(H7N9) infection in influenza A(H7N9)-affected areas of China: a serological study. J Infect Dis 2014; 209:265.</a></li><li><a class="nounderline abstract_t">Wang X, Fang S, Lu X, et al. Seroprevalence to avian influenza A(H7N9) virus among poultry workers and the general population in southern China: a longitudinal study. Clin Infect Dis 2014; 59:e76.</a></li><li><a class="nounderline abstract_t">Wang Q, Zhang Z, Shi Y, Jiang Y. Emerging H7N9 influenza A (novel reassortant avian-origin) pneumonia: radiologic findings. Radiology 2013; 268:882.</a></li><li><a class="nounderline abstract_t">Lu S, Zheng Y, Li T, et al. Clinical findings for early human cases of influenza A(H7N9) virus infection, Shanghai, China. Emerg Infect Dis 2013; 19:1142.</a></li><li><a class="nounderline abstract_t">Lin ZQ, Xu XQ, Zhang KB, et al. Chest X-ray and CT findings of early H7N9 avian influenza cases. Acta Radiol 2015; 56:552.</a></li><li><a class="nounderline abstract_t">Zhang R, Chen T, Ou X, et al. Clinical, epidemiological and virological characteristics of the first detected human case of avian influenza A(H5N6) virus. Infect Genet Evol 2016; 40:236.</a></li><li><a class="nounderline abstract_t">Yang ZF, Mok CK, Peiris JS, Zhong NS. Human Infection with a Novel Avian Influenza A(H5N6) Virus. N Engl J Med 2015; 373:487.</a></li><li><a class="nounderline abstract_t">Jiang H, Wu P, Uyeki TM, et al. Preliminary Epidemiologic Assessment of Human Infections With Highly Pathogenic Avian Influenza A(H5N6) Virus, China. Clin Infect Dis 2017; 65:383.</a></li><li><a class="nounderline abstract_t">Bi Y, Tan S, Yang Y, et al. Clinical and Immunological Characteristics of Human Infections With H5N6 Avian Influenza Virus. Clin Infect Dis 2019; 68:1100.</a></li><li class="breakAll">World Health Organization. Human infection with avian influenza A(H5) viruses
. https://www.who.int/docs/default-source/wpro---documents/emergency/surveillance/avian-influenza/ai_20220603.pdf?sfvrsn=5f006f99_97 (Accessed on June 15, 2022).</li><li><a class="nounderline abstract_t">Wei SH, Yang JR, Wu HS, et al. Human infection with avian influenza A H6N1 virus: an epidemiological analysis. Lancet Respir Med 2013; 1:771.</a></li><li><a class="nounderline abstract_t">Koopmans M, Wilbrink B, Conyn M, et al. Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands. Lancet 2004; 363:587.</a></li><li><a class="nounderline abstract_t">Nguyen-Van-Tam JS, Nair P, Acheson P, et al. Outbreak of low pathogenicity H7N3 avian influenza in UK, including associated case of human conjunctivitis. Euro Surveill 2006; 11:E060504.2.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Notes from the field: Highly pathogenic avian influenza A (H7N3) virus infection in two poultry workers--Jalisco, Mexico, July 2012. MMWR Morb Mortal Wkly Rep 2012; 61:726.</a></li><li><a class="nounderline abstract_t">Peiris M, Yuen KY, Leung CW, et al. Human infection with influenza H9N2. Lancet 1999; 354:916.</a></li><li><a class="nounderline abstract_t">Ali M, Yaqub T, Mukhtar N, et al. Avian Influenza A(H9N2) Virus in Poultry Worker, Pakistan, 2015. Emerg Infect Dis 2019; 25:136.</a></li><li><a class="nounderline abstract_t">Almayahi ZK, Al Kindi H, Davies CT, et al. First report of human infection with avian influenza A(H9N2) virus in Oman: The need for a One Health approach. Int J Infect Dis 2020; 91:169.</a></li><li><a class="nounderline abstract_t">Arzey GG, Kirkland PD, Arzey KE, et al. Influenza virus A (H10N7) in chickens and poultry abattoir workers, Australia. Emerg Infect Dis 2012; 18:814.</a></li><li><a class="nounderline abstract_t">Abdelwhab EM, Abdel-Moneim AS. Epidemiology, ecology and gene pool of influenza A virus in Egypt: will Egypt be the epicentre of the next influenza pandemic? Virulence 2015; 6:6.</a></li><li><a class="nounderline abstract_t">Qi X, Qiu H, Hao S, et al. Human Infection with an Avian-Origin Influenza A (H10N3) Virus. N Engl J Med 2022; 386:1087.</a></li><li><a class="nounderline abstract_t">Chen H, Yuan H, Gao R, et al. Clinical and epidemiological characteristics of a fatal case of avian influenza A H10N8 virus infection: a descriptive study. Lancet 2014; 383:714.</a></li><li class="breakAll">Case definitions for investigations of human infection with Avian Influenza A Viruses in the United States. Centers for Disease Control and Prevention. Available at: https://www.cdc.gov/flu/avianflu/case-definitions.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fflu%2Favianflu%2Fcase-definitions.htm (Accessed on June 10, 2022).</li><li class="breakAll">Case definitions for investigations of human infection with Avian Influenza A Viruses in the United States. Centers for Disease Control and Prevention. Available at: https://www.cdc.gov/flu/avianflu/case-definitions.html (Accessed on June 13, 2022).</li><li class="breakAll">Centers for Disease Control and Prevention. Interim Guidance on Testing, Specimen Collection, and Processing for Patients with Suspected Infection with Novel Influenza A Viruses with the Potential to Cause Severe Disease in Humans. https://www.cdc.gov/flu/avianflu/severe-potential.htm (Accessed on June 13, 2022).</li><li><a class="nounderline abstract_t">Slomka MJ, Pavlidis T, Coward VJ, et al. Validated RealTime reverse transcriptase PCR methods for the diagnosis and pathotyping of Eurasian H7 avian influenza viruses. Influenza Other Respir Viruses 2009; 3:151.</a></li><li><a class="nounderline abstract_t">Ng EK, Cheng PK, Ng AY, et al. Influenza A H5N1 detection. Emerg Infect Dis 2005; 11:1303.</a></li><li><a class="nounderline abstract_t">Majury A, Ash J, Toye B, et al. Laboratory diagnosis of human infection with avian influenza. CMAJ 2006; 175:1371.</a></li><li><a class="nounderline abstract_t">Rowe T, Abernathy RA, Hu-Primmer J, et al. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol 1999; 37:937.</a></li><li><a class="nounderline abstract_t">Uyeki TM. Human infection with highly pathogenic avian influenza A (H5N1) virus: review of clinical issues. Clin Infect Dis 2009; 49:279.</a></li><li><a class="nounderline abstract_t">Li Y, He H, Gao Y, et al. Comparison of Clinical Characteristics for Distinguishing COVID-19 From Influenza During the Early Stages in Guangdong, China. Front Med (Lausanne) 2021; 8:733999.</a></li><li><a class="nounderline abstract_t">Godaert L, Cebille A, Proye E, Dramé M. COVID-19 versus Seasonal Influenza: Comparison of Profiles of Older Adults Hospitalized in a Short-Term Geriatric Ward in France. Am J Trop Med Hyg 2021; 106:108.</a></li></ol></div><div id="topicVersionRevision">Topic 7001 Version 44.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31668198" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Novel Avian Influenza A Virus Infections of Humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31668198" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Novel Avian Influenza A Virus Infections of Humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15668219" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Probable person-to-person transmission of avian influenza A (H5N1).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18400288" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23614499" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Epidemiology of human infections with avian influenza A(H7N9) virus in China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23803488" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Comparative epidemiology of human infections with avian influenza A H7N9 and H5N1 viruses in China: a population-based study of laboratory-confirmed cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23803488" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Comparative epidemiology of human infections with avian influenza A H7N9 and H5N1 viruses in China: a population-based study of laboratory-confirmed cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17124014" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : H5N1 influenza--continuing evolution and spread.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17124015" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Avian influenza A (H5N1) infection in eastern Turkey in 2006.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17124016" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Three Indonesian clusters of H5N1 virus infection in 2005.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9482437" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16172445" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Influenza A (H5N1): will it be the next pandemic influenza? Are we ready?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15668221" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Avian influenza and pandemics--research needs and opportunities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18199865" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Update on avian influenza A (H5N1) virus infection in humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16192482" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Avian influenza A (H5N1) infection in humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15716562" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29020163" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Influenza A(H5N1) Virus Infection in a Child With Encephalitis Complicated by Obstructive Hydrocephalus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24755439" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Full-genome analysis of avian influenza A(H5N1) virus from a human, North America, 2013.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10558929" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19435433" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Clinical features of human influenza A (H5N1) infection in Vietnam: 2004-2006.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15752436" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Human disease from influenza A (H5N1), Thailand, 2004.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11930308" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Risk of influenza A (H5N1) infection among poultry workers, Hong Kong, 1997-1998.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19591579" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Risk parameters of fulminant acute respiratory distress syndrome and avian influenza (H5N1) infection in Vietnamese children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23697469" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Clinical findings in 111 cases of influenza A (H7N9) virus infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23623390" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23602315" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Emerging risk of H7N9 influenza in China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23735331" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : High severity and fatality of human infections with avian influenza A(H7N9) infection in China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28583578" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Epidemiology of avian influenza A H7N9 virus in human beings across five epidemics in mainland China, 2013-17: an epidemiological study of laboratory-confirmed case series.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23577628" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Human infection with a novel avian-origin influenza A (H7N9) virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23639487" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : The first case of H7N9 influenza in Taiwan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23633108" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Epidemiologic characteristics of cases for influenza A(H7N9) virus infections in China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23856693" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Deaths associated with avian influenza A(H7N9) virus in China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23943822" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Clinical, virological, and histopathological manifestations of fatal human infections by avian influenza A(H7N9) virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24488975" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Comparison of patients hospitalized with influenza A subtypes H7N9, H5N1, and 2009 pandemic H1N1.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23798720" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Detection of mild to moderate influenza A/H7N9 infection by China's national sentinel surveillance system for influenza-like illness: case series.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23842494" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Characterization of H7N9 influenza A viruses isolated from humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23823727" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Biological features of novel avian influenza A (H7N9) virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23718151" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Serologic study for influenza A (H7N9) among high-risk groups in China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23759348" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Serological investigation of subclinical influenza A(H7H9) infection among healthcare and non-healthcare workers in Zhejiang Province, China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27738054" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Cross-immunity Against Avian Influenza A(H7N9) Virus in the Healthy Population Is Affected by Antigenicity-Dependent Substitutions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23935201" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Avian-origin influenza A(H7N9) infection in influenza A(H7N9)-affected areas of China: a serological study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24867786" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Seroprevalence to avian influenza A(H7N9) virus among poultry workers and the general population in southern China: a longitudinal study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23821754" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Emerging H7N9 influenza A (novel reassortant avian-origin) pneumonia: radiologic findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23769184" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Clinical findings for early human cases of influenza A(H7N9) virus infection, Shanghai, China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24917607" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Chest X-ray and CT findings of early H7N9 avian influenza cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26973295" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Clinical, epidemiological and virological characteristics of the first detected human case of avian influenza A(H5N6) virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26222578" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Human Infection with a Novel Avian Influenza A(H5N6) Virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28407105" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Preliminary Epidemiologic Assessment of Human Infections With Highly Pathogenic Avian Influenza A(H5N6) Virus, China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30124826" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Clinical and Immunological Characteristics of Human Infections With H5N6 Avian Influenza Virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30124826" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Clinical and Immunological Characteristics of Human Infections With H5N6 Avian Influenza Virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24461756" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Human infection with avian influenza A H6N1 virus: an epidemiological analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14987882" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16816456" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Outbreak of low pathogenicity H7N3 avian influenza in UK, including associated case of human conjunctivitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22971746" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Notes from the field: Highly pathogenic avian influenza A (H7N3) virus infection in two poultry workers--Jalisco, Mexico, July 2012.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10489954" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Human infection with influenza H9N2.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30561309" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Avian Influenza A(H9N2) Virus in Poultry Worker, Pakistan, 2015.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31765821" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : First report of human infection with avian influenza A(H9N2) virus in Oman: The need for a One Health approach.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22516302" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Influenza virus A (H10N7) in chickens and poultry abattoir workers, Australia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25635701" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Epidemiology, ecology and gene pool of influenza A virus in Egypt: will Egypt be the epicentre of the next influenza pandemic?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35294820" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Human Infection with an Avian-Origin Influenza A (H10N3) Virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24507376" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Clinical and epidemiological characteristics of a fatal case of avian influenza A H10N8 virus infection: a descriptive study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24507376" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Clinical and epidemiological characteristics of a fatal case of avian influenza A H10N8 virus infection: a descriptive study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24507376" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Clinical and epidemiological characteristics of a fatal case of avian influenza A H10N8 virus infection: a descriptive study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24507376" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Clinical and epidemiological characteristics of a fatal case of avian influenza A H10N8 virus infection: a descriptive study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19627372" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Validated RealTime reverse transcriptase PCR methods for the diagnosis and pathotyping of Eurasian H7 avian influenza viruses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16102326" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Influenza A H5N1 detection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17116902" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Laboratory diagnosis of human infection with avian influenza.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10074505" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19522652" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Human infection with highly pathogenic avian influenza A (H5N1) virus: review of clinical issues.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34859002" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Comparison of Clinical Characteristics for Distinguishing COVID-19 From Influenza During the Early Stages in Guangdong, China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34856536" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : COVID-19 versus Seasonal Influenza: Comparison of Profiles of Older Adults Hospitalized in a Short-Term Geriatric Ward in France.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
